Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Palladini

Showing results (41-50 of 281) with videos related to

Pageof 29
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2020
Management of AL amyloidosis in 2020Giovanni Palladini, Paolo Milani, Giampaolo Merlini
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 13, 2021
In search of the most effective therapy for light chain amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Kidney International Reports|June 2, 2018
Novel Therapies in Light Chain AmyloidosisPaolo Milani, Giampaolo Merlini, Giovanni Palladini
Current Oncology Reports|June 19, 2024
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront DaratumumabClaudia Bellofiore, Giovanni Palladini, Paolo Milani
Blood|May 15, 2013
Systemic light chain amyloidosis: an update for treating physiciansGiampaolo Merlini, Ashutosh D Wechalekar, Giovanni Palladini
Circulation|January 21, 2025
AL or ATTR Amyloidosis? Never Two Without ThreeMario Nuvolone, Giuseppe D Sanna, Giovanni Palladini
The American Journal of Cardiology|August 8, 2024
Rethinking the Role of Co-morbidities in Transthyretin Cardiac Amyloidosis: Cinderella or Princess? The Case of Anemia and Iron DeficiencyGiuseppe D Sanna, Paolo Milani, Giovanni Palladini
Expert Review of Hematology|July 30, 2020
Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedsideMarco Basset, Mario Nuvolone, Giovanni Palladini, et al.
The Lancet. Haematology|October 6, 2023
Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodiesRajshekhar Chakraborty, Paolo Milani, Giovanni Palladini, et al.
European Journal of Internal Medicine|May 27, 2018
Management of the elderly patient with AL amyloidosisMario Nuvolone, Paolo Milani, Giovanni Palladini, et al.
Pageof 29

Showing results (41-50 of 281) with videos related to

Sort By:
Pageof 29
Hematology. American Society of Hematology. Education Program|December 4, 2020
Management of AL amyloidosis in 2020Giovanni Palladini, Paolo Milani, Giampaolo Merlini
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 13, 2021
In search of the most effective therapy for light chain amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Kidney International Reports|June 2, 2018
Novel Therapies in Light Chain AmyloidosisPaolo Milani, Giampaolo Merlini, Giovanni Palladini
Current Oncology Reports|June 19, 2024
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront DaratumumabClaudia Bellofiore, Giovanni Palladini, Paolo Milani
Blood|May 15, 2013
Systemic light chain amyloidosis: an update for treating physiciansGiampaolo Merlini, Ashutosh D Wechalekar, Giovanni Palladini
Circulation|January 21, 2025
AL or ATTR Amyloidosis? Never Two Without ThreeMario Nuvolone, Giuseppe D Sanna, Giovanni Palladini
The American Journal of Cardiology|August 8, 2024
Rethinking the Role of Co-morbidities in Transthyretin Cardiac Amyloidosis: Cinderella or Princess? The Case of Anemia and Iron DeficiencyGiuseppe D Sanna, Paolo Milani, Giovanni Palladini
Expert Review of Hematology|July 30, 2020
Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedsideMarco Basset, Mario Nuvolone, Giovanni Palladini, et al.
The Lancet. Haematology|October 6, 2023
Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodiesRajshekhar Chakraborty, Paolo Milani, Giovanni Palladini, et al.
European Journal of Internal Medicine|May 27, 2018
Management of the elderly patient with AL amyloidosisMario Nuvolone, Paolo Milani, Giovanni Palladini, et al.
Pageof 29